Skip to main content
Equibles

HCG · Healthcare Global Enterprises Limited · Documents

Use HCG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HCG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
572.95 INR -2.80 (-0.49%) At close · Nov 13
Rebalance outlook locked
Market Cap
85.54B INR
Shares
149.30M
Volume · Nov 13 90.48K Avg daily vol (3M) 142.14K

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Nov 6, 2026
2026
Nov 6
Earnings call
Q2 revenue rose 16%; oncology caps threaten mid-to-high single-digit EBITDA

HealthCare Global Enterprises Limited reported Q2 FY 2027 revenue of INR 7,318 million, up 16% year-on-year, and EBITDA of INR 1,425 million, up 17%, with a 19.7% margin. Oncology trade-margin caps could cause a mid-to-high single-digit annualized EBITDA impact.

4 source passages
Ladies and gentlemen, good day, and welcome to the HealthCare Global Enterprises Limited Earnings Conference Call. In Quarter 2 FY 2027, HCG delivered revenue of INR 7,318 million, representing a growth of 16% year- on- year. EBITDA for the quarter, including North Bengaluru loss of INR 61 million, was INR 1,425 million, representing growth of 17% year-on-year, with EBITDA margins improved to 19.7% compared to 19.2% in Q2FY26. Based on our assessment on an absolute basis, we estimate a mid-to-high single-digit percentage impact to EBITDA on an annualized basis. Open the document at this passage
Showing 1–3 of 3 documents